IP Library Granted Patent US 8,828,673
Granted Patent B2
US 8,828,673 · App. 13/409,952 · Granted Sep 9, 2014

Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses

Inventors: David R. Scholl (Athens, OH); Yung T. Huang (Cleveland, OH); Patricia Gail Ray Goodrum (Athens, OH)
Assignees: Diagnostic Hybrids Inc; University Hospitals of Cleveland
C12Q1/04C12Q1/18G01N2333/29C12N7/00C12N2760/16051G01N2333/295C12N2710/16611C12N2770/32311G01N2333/11C12N2770/20011
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,828,673
App. No.
13/409,952
Granted
Sep 9, 2014
Kind
B2
Abstract

The present invention generally relates to the field of diagnostic microbiology, and, more particularly; to compositions and methods for detecting and differentiating one or more viruses or other intracellular parasites present in a specimen. The present invention also provides compositions and methods to evaluate the susceptibility of organisms to antimicrobial agents.

Claims (7)

1. A method for the detection of herpes virus in a sample, comprising:

a) inoculating a mixed cell culture comprising at least MRC-5 cells and CV-1 cells with a sample suspected of containing herpes virus to produce an inoculated culture,

b) contacting said inoculated culture with an antibody that specifically binds to an antigen of said herpes virus, and

c) detecting binding of said antibody to said antigen, thereby detecting the presence of said herpes virus in said inoculated culture.

2. The method of claim 1 , wherein said herpes virus is selected from the group consisting of Herpes Simplex Type 1, Herpes Simplex Type 2, Cytomegalovirus, Varicella-Zoster Virus, Epstein-Barr Virus, Human Herpes Virus 6, Human Herpes Virus 7, and Human Herpes Virus 8.

3. The method of claim 1 , wherein said antibody comprises a fluorescent label.

4. The method of claim 1 , wherein said antibody is monoclonal.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060220/0649 →
SECURITY INTEREST Recorded Oct 6, 2017
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044141/0686 →
CHANGE OF NAME Recorded Mar 21, 2017
From: UNIVERSITY HOSPITALS OF CLEVELAND
To: UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
Reel/Frame 042742/0793 →
CHANGE OF ADDRESS Recorded Jan 12, 2017
From: DIAGNOSTIC HYBRIDS, INC.
To: DIAGNOSTIC HYBRIDS, INC.
Reel/Frame 041351/0846 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2012
From: SCHOLL, DAVID R.; GOODRUM, PATRICIA GAIL RAY
To: DIAGNOSTIC HYBRIDS, INC.
Reel/Frame 027988/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2012
From: HUANG, YUNG T.
To: UNIVERSITY HOSPITALS OF CLEVELAND
Reel/Frame 027989/0104 →
Continuity (9)
Continuation 12253127 · Oct 16, 2008
Continuation 11414760 · Apr 28, 2006
Continuation 11231552 · Sep 20, 2005
Continuation In Part 10813852 · Mar 30, 2004
Continuation In Part 10407789 · Apr 4, 2003
Continuation 09927481 · Aug 9, 2001
Continuation 09661849 · Sep 14, 2000
Division 09066072 · Apr 24, 1998
Related Publication 20120196276A1 · Aug 2, 2012